Excalibur Fund Managers Ltd - Company Review
Excalibur Fund Managers Ltd - Company ReviewSummary
Excalibur Fund Managers Ltd (Excalibur), a subsidiary of Excalibur Group Holdings Ltd is a venture capital firm that offers investment services. The firm invests in global healthcare and finance sector or co-invest in specific projects. It also manages Wales Life Sciences Fund. Excalibur is active in corporate finance and advisory, building highly successful companies from scratch, and are expert in devising growth strategies, mergers and acquisitions, capital raising, flotations, spin-offs and trades sales. The company serves governments, entrepreneurs, small drug and devices companies, universities, scientists and academics, high net worth individual investors, institutional investors, sovereign wealth funds, big pharma and national policy makers. Excalibur is headquartered in London, the UK.
This comprehensive company report of Excalibur Fund Managers Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.